CN102526312A - Medicine composition for treating calcaneodynia - Google Patents

Medicine composition for treating calcaneodynia Download PDF

Info

Publication number
CN102526312A
CN102526312A CN201210068349XA CN201210068349A CN102526312A CN 102526312 A CN102526312 A CN 102526312A CN 201210068349X A CN201210068349X A CN 201210068349XA CN 201210068349 A CN201210068349 A CN 201210068349A CN 102526312 A CN102526312 A CN 102526312A
Authority
CN
China
Prior art keywords
parts
calcaneodynia
treating
cortex
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201210068349XA
Other languages
Chinese (zh)
Other versions
CN102526312B (en
Inventor
荆兆峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210068349XA priority Critical patent/CN102526312B/en
Publication of CN102526312A publication Critical patent/CN102526312A/en
Application granted granted Critical
Publication of CN102526312B publication Critical patent/CN102526312B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a medicine composition for treating calcaneodynia, which aims to solve the problem of treating the calcaneodynia. The medicine composition for treating the calcaneodynia is characterized by being prepared from the following bulk pharmaceutical chemicals according to parts by weight: 6-12 parts of cortex acanthopanacis, 3-10 parts of pawpaw, 6-12 parts of garden balsam stem, 1-3 parts of licorice section, 6-12 parts of hematoxylon, 6-12 parts of pepper, 6-12 parts of Chinese honeylocust spine, 6-12 parts of cortex moutan, 9-15 parts of Chinese Starjasmine stem, 3-10 parts of retinervus luffae fructus, 6-15 parts of earthworm, 5-9 parts of stiff silkworm, 6-12 parts of cicada slough, 3-9 parts of setose thistle and 1-3 parts of borneol. The clinical experiment proves that the medicine composition has the characteristics of good pain relieving effect when being used for treating the calcaneodynia, and is worth for clinically applying and popularizing.

Description

A kind of pharmaceutical composition of treating calcaneodynia
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of pharmaceutical composition of treating calcaneodynia.
Background technology
Calcaneodynia is the disease of naming with heel portion pain, and being meant caused by chronic strain around the calcaneal tuberosity is master's disease with pain and difficulty in walking, often with the bony spur formation of calcaneal tuberosity portion.Primary disease is more common in 40~60 years old the person in middle and old age and the people of obesity.Clinical calcaneodynia often forms with bony spur, but the degree of talalgia is not directly proportional with the size of bony spur, and relevant with the direction of bony spur.Like the oblique below of bony spur pain is often arranged then,, can not have symptom if bony spur is parallel with calcaneus.Though it is multiple to cause that the reason of calcaneodynia has, the main cause of disease is the chronic inflammatory disease that plantar aponeurosis or heel string adhere to the place.Mostly present treatment is to wear soft sole, oral or external ntipyretic analgesic medicine, and weight person takes partial closure; But the non-invasive therapy scheme onset except that sealing is slow, analgesic effect is poor; And partial closure's shortcoming is often, is easy to recurrence, and the patient is difficult to accept.
Summary of the invention
Technical assignment of the present invention is the deficiency to above prior art, and the pharmaceutical composition of the sure treatment calcaneodynia of a kind of curative effect is provided.
The technical scheme that the present invention solves its technical problem is: a kind of pharmaceutical composition of treating calcaneodynia; It is characterized in that being processed by following bulk drugs, its weight proportion is: 6 ~ 12 parts of Cortex Acanthopanciss, 3 ~ 10 parts of Fructus Chaenomeliss, 6 ~ 12 parts of Herba speranskiae tuberculataes, 1 ~ 3 part of Radix Glycyrrhizae uralensis, 6 ~ 12 parts of Lignum Sappans, 6 ~ 12 parts in Pericarpium Zanthoxyli, 6 ~ 12 parts of Spina Gleditsiae, 6 ~ 12 parts of Cortex Moutans, 9 ~ 15 parts of Caulis Trachelospermis, 3 ~ 10 parts of Retinervus Luffae Fructuss, 6 ~ 15 parts of Pheretimas, 5 ~ 9 parts of Bombyx Batryticatus, 6 ~ 12 parts of Periostracum Cicadaes, 3 ~ 9 parts of Radix Cirsii Japonicis, 1 ~ 3 part of Borneolum Syntheticum.
Its optimum weight proportioning is: 10 parts of Cortex Acanthopanciss, 6 parts of Fructus Chaenomeliss, 10 parts of Herba speranskiae tuberculataes, 2 parts of Radix Glycyrrhizae uralensiss, 10 parts of Lignum Sappans, 10 parts in Pericarpium Zanthoxyli, 10 parts of Spina Gleditsiae, 10 parts of Cortex Moutans, 12 parts of Caulis Trachelospermis, 6 parts of Retinervus Luffae Fructuss, 12 parts of Pheretimas, 6 parts of Bombyx Batryticatus, 10 parts of Periostracum Cicadaes, 6 parts of Radix Cirsii Japonicis, 2 parts of Borneolum Syntheticums.
A kind of method for preparing of treating the pharmaceutical composition medicated bag inner core of calcaneodynia is made up of following steps:
(1) Cortex Acanthopancis, Fructus Chaenomelis, Lignum Sappan, Pericarpium Zanthoxyli, Spina Gleditsiae, Cortex Moutan, Caulis Trachelospermi, Pheretima, Bombyx Batryticatus are mixed, water cooking liquid filters behind the decocting in water, and filtrating concentrates the back drying under reduced pressure, pulverizes;
(2) Herba speranskiae tuberculatae, Periostracum Cicadae, Radix Cirsii Japonici, Radix Glycyrrhizae uralensis, Borneolum Syntheticum are pulverized;
(3), put in the medicated bag that fabric processes with adding Retinervus Luffae Fructus after step 1 and the step 2 gains mixing and stirring.
Wherein said:
Cortex Acanthopancis is the root bark of Araliaceae slender acanthopanax or Acanthopanax sessiliflorus(Rupr.et Maxim.) Seem., Radix Et Caulis Acanthopanacis Senticosi, rough leaf slender acanthopanax, acanthopanax verticillatus Hao etc.Nature and flavor are hot, and temperature is gone into liver, kidney channel.But the merit wind-damp dispelling, strengthening bone and muscle, blood circulation and promoting silt.
Fructus Chaenomelis is the dry almost ripe fruit of rosaceous plant chaenomeles lagenaria.Nature and flavor acid, temperature.Return liver, spleen channel.But merit suppressing the hyperactive liver Shujin, the stomach function regulating removing dampness.
Herba speranskiae tuberculatae is the herb of euphorbia plant speranskia tuberculata or Balsaminaceae plant Impatientis.Nature and flavor are hot, bitter, temperature.Slightly poisonous.Return liver, kidney channel.But the merit expelling wind and removing dampness, the detoxifcation pain relieving.
Radix Glycyrrhizae uralensis is for being filled with the part of brownish black, resinoid in the root of glycyrrhizic legume or the rhizome.Nature and flavor are sweet; The property; Cool; Process.GUIXIN; Liver Channel.Merit can be detoxified; Pain relieving; Sore-throat relieving; With in.
Lignum Sappan is the dry duramen of pulse family Semen Caesalpiniae platymiscium Lignum Sappan.Nature and flavor are sweet, salty, and are flat.GUIXIN, liver, spleen channel.The feasible blood and dissolving stasis of merit, reducing swelling and alleviating pain.
Pericarpium Zanthoxyli is the peel of rutaceae Pericarpium Zanthoxyli.Nature and flavor are hot, temperature.Return spleen, stomach, kidney channel.But the merit warming spleen and stomach for dispelling cold, dehumidifying, pain relieving, parasite killing.
Spina Gleditsiae is the dry Spina jujubae of leguminous plant Fructus Gleditsia.Nature and flavor are hot, temperature.Return liver, stomach warp.The merit poison holding of can subsiding a swelling, evacuation of pus, parasite killing.
Cortex Moutan is the dry root bark of ranunculaceae peony, but the merit clearing away heat and cooling blood, promoting blood circulation to remove blood stasis.
Caulis Trachelospermi is the dry zone leaf rattan of apocynaceae plant trachelospermum jasminoide.Hardship is slightly cold.GUIXIN, liver, kidney channel.But the merit dispelling wind and removing obstruction in the collateral, the removing heat from blood detumescence.
Retinervus Luffae Fructus is the vascular bundle of the dry mature fruit of cucurbitaceous plant Fructus Luffae.Sweet, flat.Return lung, stomach, Liver Channel.But the merit collateral dredging is invigorated blood circulation, and dispels the wind.
Pheretima is the dry body of Annelida hard iron earthworm section animal Pheretima aspergillum, popular Pheretimatschiliensis, William Pheretimatschiliensis or comb the region between the heart and the diaphragm hair earthworm, but the merit heat clearing away, suppressing the hyperactive liver, Zhichuan, collateral dredging.
Bombyx Batryticatus is the Bombycidae insecticide silkworm lethal dry body of larva infection (or artificial vaccination) muscardine in 4 ~ 5 ages, but the merit expelling wind for relieving convulsion, dissipating phlegm and resolving masses.
Borneolum Syntheticum is the processed goods of Dipterocarpaceae plant Borneolum Syntheticum resin, or is that Camphora, Lignum Pini Nodi wet goods are with the synthetic article of being processed into of chemical method.Nature and flavor are hot, bitter, are slightly cold.GUIXIN, spleen, lung meridian.The merit refreshment of can having one's ideas straightened out, clearing away heat to alleviate pain.
Periostracum Cicadae, exuviae shell when sprouting wings, the merit wind heat extraction that can loose, sore-throat relieving, rash, nebula removing, spasmolytic for the larva of cicada Cryptotympana atrata Fabr..
Radix Cirsii Japonici is Compositae artichoke plant Radix Cirsii Japonici herb.Go into liver, spleen channel.Nature and flavor are sweet, cold.But the merit cooling blood for hemostasis, dissipating blood stasis for subsidence of swelling.
Composition principle: calcaneodynia is had a pain for the blood stasis damp-phlegm holds in heel, so the present invention is the basis with antalgic purpose and relaxing tendons, dissipating blood stasis for subsidence of swelling, assistant is with strong kidney dispelling wind-evil and transforming calculus.The present invention gets Cortex Acanthopancis wind-damp dispelling strengthening bone and muscle, Fructus Chaenomelis Shujin, two medicines from Liver and kidney through starting with; Get the Herba speranskiae tuberculatae wind-expelling pain-stopping; Radix Glycyrrhizae uralensis detoxifcation pain relieving; The pain relieving of Lignum Sappan removing blood stasis to reduce swelling, the pain relieving of Pericarpium Zanthoxyli dispelling cold and removing dampness, this four medicine reaches rapid pain relieving purpose from different links; The Spina Gleditsiae detumescence; Cortex Moutan, the detumescence of Radix Cirsii Japonici promoting blood circulation to remove blood stasis; Caulis Trachelospermi, Retinervus Luffae Fructus, Pheretima dispelling wind and removing obstruction in the collateral; The Bombyx Batryticatus eliminating stagnation; The Periostracum Cicadae spasmolytic; Reach the local synovial bursa of improvement, the microcirculatory effect of fat pad with this, effectively prevent recurrence.Borneolum Syntheticum can clearing away heat to alleviate pain, and helps lend some impetus to above each medicine and absorb rapidly.
Compare with prior art, analgesic effect of the present invention more obviously and rapidly.
The specific embodiment
Below in conjunction with practical situation, specific embodiments of the invention elaborates.
Embodiment 1, crude drug weight: Cortex Acanthopancis 6g, Fructus Chaenomelis 5g, Herba speranskiae tuberculatae 6g, Radix Glycyrrhizae uralensis 1.5g, Lignum Sappan 6g, Pericarpium Zanthoxyli 6g, Spina Gleditsiae 6g, Cortex Moutan 6g, Caulis Trachelospermi 7.5g, Retinervus Luffae Fructus 5g, Pheretima 7.5g, Bombyx Batryticatus 4.5g, Borneolum Syntheticum 1.5g, Periostracum Cicadae 6g, Radix Cirsii Japonici 4.5g.Method for preparing: Cortex Acanthopancis, Fructus Chaenomelis, Lignum Sappan, Pericarpium Zanthoxyli, Spina Gleditsiae, Cortex Moutan, Caulis Trachelospermi, Pheretima, Bombyx Batryticatus, Retinervus Luffae Fructus are mixed in (1), and water cooking liquid filters behind the decocting in water, and filtrating concentrates the back drying under reduced pressure, pulverizes; (2) Herba speranskiae tuberculatae, Periostracum Cicadae, Radix Cirsii Japonici, Radix Glycyrrhizae uralensis, Borneolum Syntheticum are pulverized; (3) with step 1 and step 2 gains mixing and stirring.During use, above-mentioned medicamental pulverata is spread on the affected part with the mature vinegar accent.
Embodiment 2, crude drug weight: Cortex Acanthopancis 6g, Fructus Chaenomelis 3g, Herba speranskiae tuberculatae 6g, Radix Glycyrrhizae uralensis 1g, Lignum Sappan 6g, Pericarpium Zanthoxyli 6g, Spina Gleditsiae 6g, Cortex Moutan 6g, Caulis Trachelospermi 9g, Retinervus Luffae Fructus 3g, Pheretima 6g, Bombyx Batryticatus 5g, Borneolum Syntheticum 1g, Periostracum Cicadae 6g, Radix Cirsii Japonici 3g.Method for preparing: Cortex Acanthopancis, Fructus Chaenomelis, Lignum Sappan, Pericarpium Zanthoxyli, Spina Gleditsiae, Cortex Moutan, Caulis Trachelospermi, Pheretima, Bombyx Batryticatus are mixed in (1), and water cooking liquid filters behind the decocting in water, and filtrating concentrates the back drying under reduced pressure, pulverizes; (2) Herba speranskiae tuberculatae, Periostracum Cicadae, Radix Cirsii Japonici, Radix Glycyrrhizae uralensis, Borneolum Syntheticum are pulverized; (3), put in the medicated bag that fabric processes with adding Retinervus Luffae Fructus after step 1 and the step 2 gains mixing and stirring.During use, above-mentioned medicated bag is placed into the heel pain position, external socks or rubber plaster are fixed, and cannot take during walking, change once in 24 hours.The clinical research result shows that calcaneodynia patient's 28 examples are medicine for treatment with embodiment 2, effective percentage 92%, and average onset time 2.81 ± 0.64d, appearance has no adverse reaction.
Embodiment 3: crude drug weight: Cortex Acanthopancis 10g, Fructus Chaenomelis 6g, Herba speranskiae tuberculatae 10g, Radix Glycyrrhizae uralensis 2g, Lignum Sappan 10g, Pericarpium Zanthoxyli 10g, Spina Gleditsiae 10g, Cortex Moutan 10g, Caulis Trachelospermi 12g, Retinervus Luffae Fructus 6g, Pheretima 12g, Bombyx Batryticatus 6g, Borneolum Syntheticum 2g, Periostracum Cicadae 10g, Radix Cirsii Japonici 6g.Method for preparing: Cortex Acanthopancis, Fructus Chaenomelis, Lignum Sappan, Pericarpium Zanthoxyli, Spina Gleditsiae, Cortex Moutan, Caulis Trachelospermi, Pheretima, Bombyx Batryticatus are mixed in (1), and water cooking liquid filters behind the decocting in water, and filtrating concentrates the back drying under reduced pressure, pulverizes; (2) Herba speranskiae tuberculatae, Periostracum Cicadae, Radix Cirsii Japonici, Radix Glycyrrhizae uralensis, Borneolum Syntheticum are pulverized; (3), put in the medicated bag that fabric processes with adding Retinervus Luffae Fructus after step 1 and the step 2 gains mixing and stirring.During use, above-mentioned medicated bag with the heating of steamer or microwave oven, is placed into the heel pain position then, reheats behind the 20min, hot compress 20min again, every day 1 time.The clinical research result shows that calcaneodynia patient's 41 examples are medicine for treatment with embodiment 3, effective percentage 94%, and average onset time 2.15 ± 1.21d, appearance has no adverse reaction.
The prompting of this result of study, the present invention treats calcaneodynia and has good effect and the higher characteristics of safety, is worth clinical practice, popularization.

Claims (2)

1. pharmaceutical composition of treating calcaneodynia; It is characterized in that being processed by following bulk drugs, its weight proportion is: 6 ~ 12 parts of Cortex Acanthopanciss, 3 ~ 10 parts of Fructus Chaenomeliss, 6 ~ 12 parts of Herba speranskiae tuberculataes, 1 ~ 3 part of Radix Glycyrrhizae uralensis, 6 ~ 12 parts of Lignum Sappans, 6 ~ 12 parts in Pericarpium Zanthoxyli, 6 ~ 12 parts of Spina Gleditsiae, 6 ~ 12 parts of Cortex Moutans, 9 ~ 15 parts of Caulis Trachelospermis, 3 ~ 10 parts of Retinervus Luffae Fructuss, 6 ~ 15 parts of Pheretimas, 5 ~ 9 parts of Bombyx Batryticatus, 6 ~ 12 parts of Periostracum Cicadaes, 3 ~ 9 parts of Radix Cirsii Japonicis, 1 ~ 3 part of Borneolum Syntheticum.
2. a kind of pharmaceutical composition of treating calcaneodynia according to claim 1; It is characterized in that being processed by following bulk drugs, its weight proportion is: 10 parts of Cortex Acanthopanciss, 6 parts of Fructus Chaenomeliss, 10 parts of Herba speranskiae tuberculataes, 2 parts of Radix Glycyrrhizae uralensiss, 10 parts of Lignum Sappans, 10 parts in Pericarpium Zanthoxyli, 10 parts of Spina Gleditsiae, 10 parts of Cortex Moutans, 12 parts of Caulis Trachelospermis, 6 parts of Retinervus Luffae Fructuss, 12 parts of Pheretimas, 6 parts of Bombyx Batryticatus, 10 parts of Periostracum Cicadaes, 6 parts of Radix Cirsii Japonicis, 2 parts of Borneolum Syntheticums.
CN201210068349XA 2012-03-15 2012-03-15 Medicine composition for treating calcaneodynia Expired - Fee Related CN102526312B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210068349XA CN102526312B (en) 2012-03-15 2012-03-15 Medicine composition for treating calcaneodynia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210068349XA CN102526312B (en) 2012-03-15 2012-03-15 Medicine composition for treating calcaneodynia

Publications (2)

Publication Number Publication Date
CN102526312A true CN102526312A (en) 2012-07-04
CN102526312B CN102526312B (en) 2013-07-31

Family

ID=46335132

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210068349XA Expired - Fee Related CN102526312B (en) 2012-03-15 2012-03-15 Medicine composition for treating calcaneodynia

Country Status (1)

Country Link
CN (1) CN102526312B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103191384A (en) * 2013-03-31 2013-07-10 张秀兰 Medicament for treating talalgia and preparation method thereof
CN104688967A (en) * 2015-02-15 2015-06-10 青岛市市立医院 Fuming and washing liquid for treating calcaneodynia and preparation method thereof
CN105998691A (en) * 2016-06-23 2016-10-12 王翠江 Traditional Chinese medicine preparation for treating calcaneodynia and preparation method of traditional Chinese medicine preparation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101099773A (en) * 2007-07-18 2008-01-09 蒋保珍 Hyperosteogeny-treating plaster
KR20080043062A (en) * 2006-11-13 2008-05-16 주식회사 핸슨바이오텍 Anti-inflammatory agent containing silkworm hemolymph
CN101601767A (en) * 2009-01-14 2009-12-16 杨群英 A kind of Chinese medicine lotion for the treatment of calcaneodynia
CN101972376A (en) * 2010-09-29 2011-02-16 韩世昌 Chinese medicinal ointment for treating intervertebral disc hyperosteogeny and preparation method thereof
CN102188121A (en) * 2011-05-04 2011-09-21 惠州市欧野科技有限公司 Traditional Chinese medicine mattress capable of treating rheumatism

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080043062A (en) * 2006-11-13 2008-05-16 주식회사 핸슨바이오텍 Anti-inflammatory agent containing silkworm hemolymph
CN101099773A (en) * 2007-07-18 2008-01-09 蒋保珍 Hyperosteogeny-treating plaster
CN101601767A (en) * 2009-01-14 2009-12-16 杨群英 A kind of Chinese medicine lotion for the treatment of calcaneodynia
CN101972376A (en) * 2010-09-29 2011-02-16 韩世昌 Chinese medicinal ointment for treating intervertebral disc hyperosteogeny and preparation method thereof
CN102188121A (en) * 2011-05-04 2011-09-21 惠州市欧野科技有限公司 Traditional Chinese medicine mattress capable of treating rheumatism

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王曙东等: "中医洗浴疗法的应用", 《时珍国医国药》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103191384A (en) * 2013-03-31 2013-07-10 张秀兰 Medicament for treating talalgia and preparation method thereof
CN103191384B (en) * 2013-03-31 2014-06-18 张秀兰 Medicament for treating talalgia and preparation method thereof
CN104688967A (en) * 2015-02-15 2015-06-10 青岛市市立医院 Fuming and washing liquid for treating calcaneodynia and preparation method thereof
CN105998691A (en) * 2016-06-23 2016-10-12 王翠江 Traditional Chinese medicine preparation for treating calcaneodynia and preparation method of traditional Chinese medicine preparation

Also Published As

Publication number Publication date
CN102526312B (en) 2013-07-31

Similar Documents

Publication Publication Date Title
CN102091234B (en) Traditional Chinese medicine composition for treating bone fracture diseases
CN101095785A (en) Chinese traditional medicine composition for treating arthritis hyperosteogeny intervertebral disc hernia ion
CN103007215A (en) Chinese medicinal composition for treating edema
CN103816292B (en) Traditional Chinese medicine foot bath powder and preparation method thereof
CN102526312B (en) Medicine composition for treating calcaneodynia
CN101711804B (en) Traditional Chinese medicine paste for treating leukoderma diseases
CN104906482B (en) A kind of Goupi Gao and preparation method thereof
CN103394042B (en) A kind of Traditional Chinese medicine tincture preparation of auxiliary treatment bone fracture
CN105435197A (en) Pharmaceutical composition for treating chronic lymphocytic thyroiditis and preparation method thereof
CN108635419A (en) A kind of Chinese medicine composition for treating urarthritis
CN104758369B (en) A kind of Chinese medicine composition and its preparation method and application
CN105878776A (en) Pharmaceutical composition and preparation for treating neck, shoulder, waist and leg diseases and preparation method and application of the pharmaceutical composition and the preparation
CN102526313B (en) Method for preparing medicinal composition bag stuffing for treating heel pain
CN104399048A (en) Traditional Chinese medicine for treating stomach cancer and treatment method of traditional Chinese medicine
CN108114112A (en) A kind of blood-activating analgetic plaster and preparation method thereof
CN109106883A (en) A kind of pharmaceutical composition for treating eczema
CN107823343A (en) A kind of pharmaceutical composition for treating rheumathritis and medicinal liquor and preparation method thereof
CN105749180A (en) Traditional Chinese medicine composition used for treating angina
CN106581251A (en) Traumatic injury treating Yao medicine external application medicinal wine and preparation method thereof
CN104958590A (en) Preparing method for breast micro-calcification external used medicine
CN104689183A (en) Medicinal liquor with swelling eliminating and blood stasis dispersing functions and preparing method thereof
CN104645061A (en) Medicine for treating blood stasis stationary chronic gastric ulcer and preparation method
CN104474440A (en) Pharmaceutical composition for treatment of nutritional anemia of piglets and preparation method thereof
CN104083465A (en) Medicinal liquor for treating sciatica and lumbar muscle strain and preparation method
CN108888743A (en) It is a kind of for treating the Chinese medicine composition of pectoralgia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130731

Termination date: 20140315